Cancer Cells Discovered to Secrete a Protein That Supports Tumor Growth

Cancer cells need to take control of surrounding cells in order to proliferate and spread. Studies so far have shown that this may occur through specific proteins. In this context, in March 2019, Scientific Reports published a study in which prostate cancer cells were discovered to secrete a protein called EN2, changing the behavior of normal cells and other cancer cells. This protein also enables cancer cells to evade the immune system more easily .
The research was conducted jointly by the University of Bradford and the University of Surrey in the United Kingdom. Researchers labeled the EN2 protein with green fluorescence and examined these cells’ activities in prostate cancer cells, normal prostate cells, bladder cancer cells, skin cancer cells, and blood cancer cells. EN2 (Engrailed-2) is a transcription factor involved in brain development. However, EN2 activity has been found to be elevated in many cancer cell types.
According to the research results;
- Prostate cancer cells were observed to release the EN2 protein into their surroundings. Normal cells and cancer cells were found to take up this protein from the external environment.
- Real-time imaging also photographed prostate cancer cells over 24 hours at intervals of 5 minutes. The resulting videos showed prostate cancer cells releasing green-labeled EN2 proteins into their surroundings and these proteins being taken up by dormant cancer cells . Cancer cells taking up this protein became active again, changed shape, or fused with one another (joined together). Cell fusion is highly unusual in cancer and is associated with aggressive growth. Such fused cells have a new, previously unpredictable genetic makeup. They therefore show effective drug resistance .
- Molecular analyses of prostate cancer cells that took up EN2 showed that the EN2 protein increased MX2 gene expression. The MX2 gene plays an important role in antiviral immune responses. This suggests an effort to minimize the risk of surrounding cells becoming “infected” by viruses. In this way, evading the immune system’s attention becomes easier. This may also play a role in reducing the effectiveness of immunotherapies based on oncolytic viruses .

Figure explanation: EN2 secretion produces antiviral changes in the stroma. In cancer cells expressing EN2 (shown in green), the EN2 protein is found both in the nucleus and in microvesicles on the cell membrane. These microvesicles can be secreted and taken up by other cells (cancer or normal cells). In normal cells, EN2 increases MX2 gene expression, enabling an immune response against viral infections.
Another interesting finding is that EN2 is present in both the cell membrane and the nucleus. This is highly unusual for a protein. Therefore, EN2 may be a potential target for new and effective cancer treatments.
What Does This Study Mean for Us?
- Tumors need to control surrounding cancer cells and normal cells in order to proliferate and spread (see the tumor microenvironment). This study discovered that prostate cancer cells try to control surrounding cells by secreting EN2 protein. Approaches targeting this protein may offer effective cancer treatment.
- The EN2 protein may be an important diagnostic and prognostic (predictive of disease course) biomarker in prostate cancer.
Sources
Membrane insertion and secretion of the Engrailed-2 (EN2) transcription factor by prostate cancer cells may induce antiviral activity in the stroma.
Scientific Reports, 26 March 2019.
Was this article helpful?
Your feedback helps us improve our content.





Reader comments
Share your comment
Your name and comment are published only after administrator approval. Your email address is never shown to visitors.
Be the first to comment.